Recombinant Human DCD Protein，His

DCD (Defensin Cationic Peptide) is a type of antimicrobial peptide that plays a crucial role in the innate immune system of various organisms. Research in this area has gained significant attention due to the increasing need for novel antimicrobial agents amidst the rising global threat of antibiotic resistance. DCD proteins are known for their effectiveness against a wide range of pathogens, including bacteria, fungi, and viruses, by disrupting microbial membranes and inhibiting vital cellular processes. The unique structure of DCD, which includes a cationic nature and amphipathic properties, enhances their interaction with negatively charged microbial membranes, making them potent agents for therapeutic applications. Studies have examined the recombinant expression of DCD to produce these peptides in sufficient quantities for further analysis, enabling researchers to explore their mechanisms of action, optimize their antimicrobial efficacy, and evaluate their potential as therapeutic candidates. Additionally, the use of recombinant technology allows for modifications that could improve stability and reduce the likelihood of resistance development. Overall, the investigation of DCD and its recombinant forms holds promise for advancing our understanding of innate immunity and provides innovative strategies for combating infections in a post-antibiotic world.